The role of p53 in pigmentation, tanning and melanoma

被引:67
作者
Box, Neil F. [1 ]
Terzian, Tamara [1 ]
机构
[1] Univ Colorado, Dept Dermatol, Aurora, CO USA
关键词
melanoma; pigmentation; progression; skin; p53; apoptosis; sunburn;
D O I
10.1111/j.1755-148X.2008.00495.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
p53 has a central role in skin pigmentation and may impact on melanoma at all stages, however, as it's mutation frequency in melanoma is low, it's role has been somewhat under-appreciated. During normal skin function, p53 in the keratinocyte is a transducer of the skin tanning signal and an essential component of what is effectively a keratinocyte-melanocyte signaling cycle that regulates skin pigmentation. It is clear that this cycle functions optimally in skin of dark pigmentation. When melanin biosynthesis is genetically disrupted in skin of white complexion, we propose that this cycle operates as a promoter of melanocyte proliferation. The cell autonomous function of p53 in melanocytes is not well described, however, the balance of the evidence suggests that p53 is an effective tumor suppressor and the myriad of mechanisms by which the p53 pathway may be dysregulated in tumors attests to it importance as a tumor suppressor. In this review, we outline the known mechanisms that impair p53 itself and its immediate regulators or target genes during melanomagenesis. Due to the importance of this pathway, it is clear that p53 disruptions may relate directly to a patient's prognosis. This pathway will continue to be a focus of investigation, particularly with respect to targeted experimental chemotherapeutics.
引用
收藏
页码:525 / 533
页数:9
相关论文
共 85 条
[1]   High doses of ultraviolet-C irradiation increases vasoactive intestinal contractor/endothelin-2 expression in keratinocytes of the newborn mouse epidermis [J].
Adur, Javier ;
Takizawa, Satoshi ;
Uchide, Tsuyoshi ;
Casco, Victor ;
Saida, Kaname .
PEPTIDES, 2007, 28 (05) :1083-1094
[2]   MUTATION AND EXPRESSION OF THE P53 GENE IN HUMAN-MALIGNANT MELANOMA [J].
ALBINO, AP ;
VIDAL, MJ ;
MCNUTT, NS ;
SHEA, CR ;
PRIETO, VG ;
NANUS, DM ;
PALMER, JM ;
HAYWARD, NK .
MELANOMA RESEARCH, 1994, 4 (01) :35-45
[3]   Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin [J].
Avery-Kiejda, Kelly A. ;
Zhang, Xu Dong ;
Adams, Luke J. ;
Scott, Rodney J. ;
Vojtesek, Borivoj ;
Lane, David P. ;
Hersey, Peter .
CLINICAL CANCER RESEARCH, 2008, 14 (06) :1659-1668
[4]   Dual inactivation of RB and p53 pathways in RAS-induced melanomas [J].
Bardeesy, N ;
Bastian, BC ;
Hezel, A ;
Pinkel, D ;
DePinho, RA ;
Chin, L .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (06) :2144-2153
[5]   Classifying melanocytic tumors based on DNA copy number changes [J].
Bastian, BC ;
Olshen, AB ;
LeBoit, PE ;
Pinkel, D .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (05) :1765-1770
[6]   Automated quantitative analysis of HDM2 expression in malignant melanoma shows association with early-stage disease and improved outcome [J].
Berger, AJ ;
Camp, RL ;
DiVito, KA ;
Kluger, HM ;
Halaban, R ;
Rimm, DL .
CANCER RESEARCH, 2004, 64 (23) :8767-8772
[7]   Induction of melanoma phenotypes in human skin by growth factors and ultraviolet B [J].
Berking, C ;
Takemoto, R ;
Satyamoorthy, K ;
Shirakawa, T ;
Eskandarpour, M ;
Hansson, J ;
VanBelle, PA ;
Elder, DE ;
Herlyn, M .
CANCER RESEARCH, 2004, 64 (03) :807-811
[8]   Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin [J].
Berking, C ;
Takemoto, R ;
Satyamoorthy, K ;
Elenitsas, R ;
Herlyn, M .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (03) :943-953
[9]   Role of Apaf-1, a key regulator of apoptosis, in melanoma progression and chemoresistance [J].
Campioni, M ;
Santini, D ;
Tonini, G ;
Murace, R ;
Dragonetti, E ;
Spugnini, EP ;
Baldi, A .
EXPERIMENTAL DERMATOLOGY, 2005, 14 (11) :811-818
[10]   LACK OF ALLELIC DELETION AND POINT MUTATION AS MECHANISMS OF P53 ACTIVATION IN HUMAN-MALIGNANT MELANOMA [J].
CASTRESANA, JS ;
RUBIO, MP ;
VAZQUEZ, JJ ;
IDOATE, M ;
SOBER, AJ ;
SEIZINGER, BR ;
BARNHILL, RL .
INTERNATIONAL JOURNAL OF CANCER, 1993, 55 (04) :562-565